Some diseases are not so scary for only one reason – for their treatment there are medicines that can be bought at the pharmacy. In the case of COVID-19, medicine does not yet have available drugs that can defeat the coronavirus, but there is good news. The American pharmaceutical company Pfizer is developing a drug for COVID-19 and has even begun clinical trials of it. If all goes well and he gets FDA approval, the drug will be on sale by the end of this year.
“We are working on the creation of two variants of the drug for coronavirus, which can be used for treatment at home. Hopefully, these drugs will work against the new strains of COVID-19 as well. The first option is injection. The second is oral. We are now actively working on this and expect to share some good news by the summer, ”said Pfizer CEO Albert Bourla.
The drug the company is working on belongs to a class of drugs known as protease inhibitors. Such drugs are used to treat other viral infections, such as HIV or hepatitis C. It works by inhibiting (the process of suppressing or delaying the reaction) of the enzyme of the COVID-19 virus, which the virus needs to replicate itself in human cells.
The medicine is intended for those who have just contracted the coronavirus and can prevent the progression of the disease. In this case, the patient may not need the help of doctors, which can reduce the burden on the health care system.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
